Genetic variants that change how genes are regulated in specific cell types are closely tied to disease, according to new research based on single-cell profiling of nearly 2,000 people. The findings bring scientists closer to understanding how differences in human DNA translate into differences in gene expression and, ultimately, in health.
Most people carry many genetic variations, and the vast majority have no obvious effect on their well-being. Many of these variants, however, lie in regions of the genome that control when and how strongly genes are switched on. Because the same gene can behave differently depending on the cell in which it operates, researchers have found it difficult to pinpoint which variants matter and where they act. Studying gene expression at the level of individual cells makes it possible to see those cell-specific effects that broader, averaged measurements can obscure.
The research pairs genetic information with detailed measurements of gene activity across many cell types drawn from a large group of participants. By linking particular variants to changes in gene expression within specific cells, the work helps clarify the chain that runs from a inherited genetic difference to a shift in cellular behavior, and from there to disease risk. That link is central to understanding why some people develop certain conditions while others do not.
The study is part of a broader push in biomedicine to move beyond identifying genetic associations with disease toward explaining the biological mechanisms behind them. Knowing which cell types are affected by a given variant can help researchers prioritize targets for future study and point toward where treatments might act.
A separate study published in Nature Medicine adds a related perspective from the immune system. Researchers examining amyotrophic lateral sclerosis, or ALS, found that persistent T cell responses relate to disease outcome differently in the blood than in the cerebrospinal fluid that bathes the brain and spinal cord. Both intrathecal antigen presentation, which occurs within the central nervous system, and cytomegalovirus-specific immunity were linked to worse clinical outcomes. The results suggest that immune activity in distinct body compartments can follow different patterns and carry different implications for patients.
Taken together, the two studies underline a common theme: disease often depends on what is happening inside particular cells and tissues rather than on averages across the whole body. Understanding that compartmentalization, whether in gene regulation or immune response, is becoming essential to explaining how illness develops and to designing therapies that act where they are needed.
19
